Annals of Oncology
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Annals of Oncology
Jul 25, 2024, 13:49 |
Insight
Luca Arecco: Impact of hormone receptor status and tumor subtypes on prognosis of breast cancer in young BRCA carriers
Luca Arecco, Medical Oncology Resident at IRCCS Ospedale Policlinico San Martino, on X: "Published in…
Jul 25, 2024, 00:35 |
Insight
Rodrigo Sánchez-Bayona: Our editorial on CDK4/6i impacted the OS in first-line for HR+/HER2- advanced breast cancer
Rodrigo Sánchez-Bayona, Medical Oncologist specialising in breast and gynecological cancers at 12 de Octubre University Hospital,…
Jul 23, 2024, 11:27 |
Insight
Luca Malorni: Our editorial discussing the results of the SERENA-1 trial
Luca Malorni, Director of the Translational Research Unit at AUSL Toscana Centre at Hospital of…
Jul 19, 2024, 14:02 |
Insight
The results of the IMpassion132 trial
Elisa Agostinetto shared on X a paper by Rebecca Dent et al. titled "IMpassion132 double-blind…
Jul 12, 2024, 17:41 |
Blog
Raffaella Casolino: Insights from WHA77 and WHO Global Status Report on Cancer 2025
Raffaella Casolino, Technical Officer at World Health Organization and Honorary Clinical Senior Lecturer at University…
Jul 11, 2024, 04:05 |
Blog
Annals of Oncology - Long-term results of the UNICANCER-PRODIGE 23 trial
Annals of Oncology shared on X: "New article in press: Total neoadjuvant therapy with mFOLFIRINOX versus…
Jul 9, 2024, 06:03 |
Insight
Translational Breast Cancer Research Consortium Trial 022 - Annals of Oncology
Annals of Oncology made the following post on X: "New article in press: Neratinib and Ado-Trastuzumab-Emtansine…
Jul 6, 2024, 13:29 |
Blog
ESMO - immune cell-related biomarkers in metastatic HNSCC
ESMO shared on LinkedIn: "Latest podcast. Annals of Oncology Editor in Chief Tom Powles talks to…
Jul 4, 2024, 12:28 |
Blog
Emir Sokolović: The largest study focusing on young women with breast cancer carrying germline BRCA PV
Emir Sokolović, Medical Oncology Resident at Clinical center University of Sarajevo, shared on LinkedIn: "Our…
Jul 3, 2024, 18:13 |
Blog
Alessandro Di Federico: Intrapatient variation in PD-L1 and TMB
Alessandro Di Federico, Medical Oncologist and PhD student at University of Bologna, shared a post on…
Jul 2, 2024, 12:04 |
Career
Luca Arecco was awarded the ASCO Conquer Cancer Merit Award
Matteo Lambertini shared a post by San Martino Hospital, Genova on X, adding: “Congrats Luca Arecco…
Jul 1, 2024, 15:01 |
Blog
Antonio Passaro: A significant milestone for the advancement and understanding of EGFR-mutated NSCLC
Antonio Passaro, shared a post on LinkedIn: "I am honored to have contributed, as investigator…
Jul 1, 2024, 13:46 |
Blog
The July issue of Annals of Oncology
Annals of Oncology shared a post on LinkedIn: “New online - the July issue of…
Jun 28, 2024, 11:08 |
Insight
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results Authors: E. Felip, B.C.…
Jun 23, 2024, 14:32 |
Blog
Impact of Hormone Receptor Status and Tumor Subtypes of Breast Cancer in Young BRCA Carriers
Matteo Lambertini shared a post by Annals of Oncology, on X: "Presented at ASCO24 by Luca Arecco and…
Jun 22, 2024, 14:12 |
Insight
New Paper Alert! Novel Tool Predicts Chemotherapy Response in Pancreatic Cancer Using AI-assisted Transcriptomic Signatures
Novel Tool Predicts Chemotherapy Response in Pancreatic Cancer Using AI-assisted Transcriptomic Signatures Authors: Nicolas Fraunhoffer,…
Jun 19, 2024, 12:19 |
Blog
Oncology Advance - See this month’s highlights from the ESMO portfolio
Oncology Advance shared a post on X: "See this month’s highlights from the ESMO portfolio. Featured…
Jun 15, 2024, 07:36 |
Blog
Tom Powles and Giorgio Bogani Discuss the Recently Published Study on Advanced or Recurrent Endometrical Cancer
The European Society for Medical Oncology (ESMO) posted on LinkedIn: “Latest podcast Annals of Oncology Editor-in-Chief…
Jun 12, 2024, 01:33 |
Insight
Upfront resection versus no resection of the primary tumor in patients with synchronous mCRC - Julius Center Research Program Cancer
Julius Center Research Program Cancer shared a post on LinkedIn: …
Jun 10, 2024, 11:27 |
Insight
Arndt Vogel on a paper by D.E.W. van der Kruijssen et al.
Arndt Vogel shared a post on X: "Upfront resection vs no resection of the primary…
Jun 10, 2024, 10:31 |
Opinion
Armando Orlandi: To explain the unexplainable in MONARCH 3
Armando Orlandi, Medical Oncologist at Agostino Gemelli University Policlinic, made the following post on X:…
Jun 7, 2024, 09:11 |
Insight
Erika Hamilton: Happy to share the publication in Annals of Oncology
Erika Hamilton shared a post on X: “Happy to share the publication in Annals of…
May 24, 2024, 13:24 |
Insight
Erman Akkus Summarizes 5-year Results of CheckMate 040
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: “Nivolumab plus ipilimumab…
May 24, 2024, 11:17 |
Insight
Piotr Wysocki: Patients with hypermutated colorectal cancer (POLE/D1pd) derive profound benefit from immunotherapy
Piotr Wysocki recently posted on LinkedIn: "Ambrosini N et al. published online (Annals of Oncology) the…
May 14, 2024, 14:59 |
Blog
Annals of Oncology March 2024 issue article of the month
Annals of Oncology shared a post by Annals of Oncology on X/Twitter, adding: ''The article…
May 13, 2024, 07:59 |
Blog
Erika Hamilton: Check out our new practice LinkedIn page
Erika Hamilton shared a post by SCRI Oncology Partners on LinkedIn, adding: ''Check out our new practice…
May 12, 2024, 14:34 |
Societies
Tom Powles talks to Amanda Psyrri about immune cell-related biomarkers in HNSCC - ESMO
ESMO - European Society for Medical Oncology shared on LinkedIn: “Latest podcast Annals of Oncology…
May 9, 2024, 11:35 |
Insight
Vivek Subbiah: SERENA-1 monotherapy results in Annals of Oncology
Quoting Vivek Subbiah on X: . "A Phase 1 dose escalation and expansion trial of…
Apr 23, 2024, 20:12 |
Blog
Antonio Passaro: An honor to have been a part of this significant manuscript, just out in Annals of Oncology driving forward the clinical development of ADCs
Antonio Passaro, Medical Director with Highly Specialized Position at IEO European Institute of Oncology, shared on…
Apr 23, 2024, 11:38 |
Insight
Antonio Passaro: ETOP IBCSG Partners Foundation's position statement on antibody-drug conjugates (ADC) in lung and breast cancer
Antonio Passaro, Lung cancer Oncologist and Researcher at IEO, recently shared on X: "Just out…
Apr 22, 2024, 19:23 |
Insight
New Paper Alert! A Comprehensive Review of ADCs in Lung and Breast Cancer by the ETOP IBCSG Partners Foundation
A Comprehensive Review of ADCs in Lung and Breast Cancer by the ETOP IBCSG Partners…
Apr 15, 2024, 17:01 |
Drugs
Elisa Agostinetto: It’s likely that adjuvant Pembrolizumab has a lower impact compared to neoadjuvant Pembrolizumab
Elisa Agostinetto, Research Physician at the Institute of Jules Bordet in Brussels, posted on X/Twitter:…
Apr 12, 2024, 09:26 |
Insight
In this Letter to the Editor, the Cancer Immunotherapy AEs Working Group details the pitfalls of reporting in immunotherapy clinical trials - Annals of Oncology
Annals of Oncology shared a post on X: "Immune checkpoint inhibitors are now standard-of -care in…
Mar 17, 2024, 19:51 |
Insight
Tom Powles: New ESMO's guidlines for advanced bladder cancer Annals of Oncology - Enforumab Vedotin and pembrolizumab is the new standard of care
Tom Powles, Director of Barts Cancer Center, shared a post on X: "New ESMO's guidelines for…
Mar 15, 2024, 15:26 |
Insight
Enfortumab+pembrolizumab combination as the 1st line treatment of choice for advanced urothelial cancer - summary by Piotr J. Wysocki
Piotr J. Wysocki, Professor of Medicine, Head of Department of Oncology at Jagiellonian University Hospital,…
Feb 28, 2024, 12:34 |
Blog
Erman Akkus: Early onset colorectal cancer, 2 recent studies
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "Early onset colorectal cancer…
Feb 21, 2024, 18:13 |
Insight
Erman Akkus: Tremelimumab plus durvalumab (STRIDE) in HCC-HIMALAYA update
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "Tremelimumab plus durvalumab (STRIDE)…
Feb 10, 2024, 15:34 |
Insight
Alessandro Russo: Our editorial on the potential role of ctDNA in resectable NSCLC undergoing neo-adj chemo
Alessandro Russo, Medical Oncologist at A.O. Papardo, Messina, recently shared the following insight on X/Twitter:…
Jan 4, 2024, 16:59 |
Insight
Vinay Prasad: When do the checkpoint inhibitors work
Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Jan 3, 2024, 20:43 |
Opinion
Erman Akkus: Future biomarkers will be more than PD-L1 for ICI
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: “B-cell infiltration as a…
Dec 31, 2023, 06:06 |
Blog
David Gandara: “not so fast”
David Gandara, Director of Thoracic Oncology and Senior Advisor to the Director at University of…
Dec 15, 2023, 15:59 |
Insight
,
Opinion
Vivek Subbiah: Precision Medicine for FGFR in bladder cancer has now arrived
Vivek Subbiah shared on X/Twitter: “Just published Annals of Oncology. Pleased to share our editorial "Unlocking…
Nov 21, 2023, 13:57 |
Blog
Vivek Subbiah: Honored to co-author with brilliant "Guru" of bladder cancer Guru Sonpavde.
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Sep 7, 2023, 22:03 |
Insight
Arndt Vogel: We provide comprehensive recommendations for PDAC.
Arndt Vogel, Managing senior consultant and professor in the Department of Gastroenterology, Hepatology and Endocrinology…
Aug 23, 2023, 23:49 |
Blog
Paolo Tarantino: Interesting pan-cancer evaluation of HER2-low expression out on Annals of Oncology.
Paolo Tarantino, a Research Fellow at the Dana-Farber Cancer Institute, shared the following insights on…
All:
45
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube